Mahkam Zanganeh, Chief Executive Officer at Summit Therapeutics Inc. (SMMT), bought 810,495 shares at $2.07 ($1.2M) on 2023-12-12, disclosed to the SEC on 2023-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.44 | 489,814 | $705K | 58.1% |
| 2 | $1.58 | 315,681 | $499K | 41.1% |
| 3 | $2.07 | 5,000 | $10K | 0.9% |
| Total | $1.50 avg | 810,495 | $1.2M | 100% |
| Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| SMMT | BUY | 2025-09-11 | $11.9M | — | Filing → |
| SMMT | BUY | 2024-03-27 | $539K | — | Filing → |